HomeInsightsMarket Capitalization

Market Capitalization of Medicamen Biotech Ltd

Market Capitalization of Medicamen Biotech Ltd

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

0.2 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 08, 2024

Image

Medicamen Biotech Ltd

NSE: MEDICAMEQ

MARKETCAP

₹ 657.92 crore

Last updated on: Nov 07, 2024

Key Highlights

  • The Market Cap of Medicamen Biotech Ltd is ₹ 657.92 crore as of 07 Nov 24.
  • The Market Cap of Medicamen Biotech Ltd changed from ₹ 567.33 crore on March 2019 to ₹ 487.1 crore on March 2024 . This represents a CAGR of -2.51% over 6 years. .
  • The Latest Trading Price of Medicamen Biotech Ltd is ₹ 523.5 as of 08 Nov 09:47.
  • The Dividend Payouts of Medicamen Biotech Ltd changed from ₹ 1 to ₹ 1 over 6 quarters. This represents a CAGR of 0.00% .

Historical Market Cap of Medicamen Biotech Ltd

No data available

* All values are in crore

Company Fundamentals for Medicamen Biotech Ltd

No data available

Image

Medicamen Biotech Ltd

NSE: MEDICAMEQ

PRICE

₹ 523.5

6.05 (1.17%)

stock direction

Last updated on: Nov 08 09:47 AM

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Medicamen Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 2024517.45
06 Nov 2024527.4
05 Nov 2024527.95
04 Nov 2024531.45
01 Nov 2024552.95
31 Oct 2024536.2
30 Oct 2024546.3
29 Oct 2024486.1
28 Oct 2024495.15
25 Oct 2024498.75

SWOT Analysis Of Medicamen Biotech Ltd

Strength

4

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Medicamen Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Medicamen Biotech Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Medicamen Biotech Ltd

No data available

No data available

Historical P/E Ratio of Medicamen Biotech Ltd

No data available

* All values are in %

Historical Revenue of Medicamen Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Medicamen Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Medicamen Biotech Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Medicamen Biotech Ltd

No data available

* All values are in

About Medicamen Biotech Ltd

  • Medicamen Biotech Ltd is a widely held, Globally Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets.
  • The company is engaged in manufacture and distribution of medicines.
  • They manufacturer and supply the range of products such as tablets, capsules, liquid syrup and dry syrup (beta lactum and non beta lactum) and ointment. The company has two manufacturing facilities namely, Bhiwadi (Rajasthan) and Haridwar (Uttarakhand).
  • The Bhiwadi unit has ultra modern production facilities incorporating latest state of the art technology with a combination of technically qualified personnel and hardworking workforce.
  • In Haridwar unit, the company manufactures Non-Betalactum preparations including tablets, capsules, oral liquids and ointments & creams.

Medicamen Biotech Ltd News Hub

News

Medicamen Biotech to conduct AGM

Medicamen Biotech announced that the Annual General Meeting (AGM) of the company will be h...

Read more

13 Sep 202411:43

News

Medicamen Biotech to conduct board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 13 Augus...

Read more

12 Aug 202410:31

News

Board of Medicamen Biotech recommends Final Dividend

Medicamen Biotech announced that the Board of Directors of the Company at its meeting held...

Read more

29 May 202417:32

News

Medicamen Biotech schedules board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 29 May 2...

Read more

25 May 202415:28

News

Medicamen Biotech to conduct board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 12 Febru...

Read more

06 Feb 202414:01

News

Medicamen Biotech to convene board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 10 Novem...

Read more

06 Nov 202311:18

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Medicamen Biotech Ltd Market Cap

What is the market cap of Medicamen Biotech Ltd?

As of November 8, 2024, Medicamen Biotech Ltd has a market capitalization of ₹657.92, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Medicamen Biotech Ltd's market capitalization?

Medicamen Biotech Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Medicamen Biotech Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Medicamen Biotech Ltd's market capitalization change?

Medicamen Biotech Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*